Physician profile
Ryan Leonard
NPI 1649460163
$1,789.54
in general payments reported to CMS, 2019-2025
18 companies · $54.79 in 2025
The $54.79 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $1,392 · 2021: $46.91 · 2022: $42.54 · 2024: $88.82 · 2025: $54.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,384.16 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.53 | 2019-2025 | Jardiance |
| Amgen INC. | $46.59 | 2019 | |
| Mylan Specialty L.P. | $37.95 | 2020 | |
| Glaxosmithkline, LLC. | $33.29 | 2022-2024 | Nucala |
| Astrazeneca Pharmaceuticals LP | $28.89 | 2019 | |
| Dexcom, INC. | $23.28 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.27 | 2025 | |
| Corcept Therapeutics | $19.50 | 2024 | Korlym |
| Welch Allyn | $19.16 | 2021 | |
| Neurocrine Biosciences, INC. | $19.15 | 2024 | Ingrezza |
| Aerin Medical INC. | $18.31 | 2024 | |
| Inspire Medical Systems, INC. | $16.83 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $15.55 | 2019 | |
| Acclarent, INC | $13.62 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $13.62 | 2024 | |
| Cook Medical LLC | $11.93 | 2021 | |
| Lilly USA, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.